Abstract
Immunoglobulin A nephropathy is a rare renal condition, and despite a large number of cases progressing to end-stage kidney disease, the mechanisms behind the illness are not fully understood. Haresh Selvaskandan, Melanie Dillon and Jonathan Barratt discuss how having access to an international rare disease registry with data on this disease can help improve kidney care around the world.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
